Three more child flu deaths were reported, all from influenza B.
The Democratic Republic of the Congo's (DRC's) Ebola technical committee said there are three new cases of Ebola today, raising the outbreak total to 3,343, and 432 suspected cases are under investigation.
The technical committee, the CMRE, said the death toll now stands at 2,210. Today's cases come from Mabalako and Biena, which had gone 85 days without a new case.
The study was a head-to-head look at 3 vaccines targeted to seniors against the standard vaccine.
According to Avian Flu Diary, an infectious disease tracking blog, Taiwan's Centers for Disease Control and Ministry of Health today reported two human cases of H9N2 avian flu originating in mainland China were reported to the World Health Organization in November.
Yesterday the Centers for Disease Control and Prevention (CDC) said 35 more people have been sickened in an Escherichia coli outbreak tied to romaine lettuce grown near Salinas, California.
The outbreak total now stands at 102 illnesses in 23 states, with 4 states reporting their first cases.
Public Health England (PHE) today confirmed that a person in the southwest of England has been diagnosed as having monkeypox, likely contracted after a recent visit to Nigeria.
The United Kingdom documented its first cases of the rare virus last year, in two patients who also likely contracted the disease in Nigeria, plus a case involving a healthcare worker—the first instance of spread of the disease in the country.
Pakistan, Nigeria, the Democratic Republic of the Congo (DRC), and Angola each reported new cases of vaccine-derived polio, according to the latest weekly update today from the Global Polio Eradication Initiative (GPEI), and Pakistan also confirmed cases involving the wild-type virus.
In updates yesterday and today, Saudi Arabia's Ministry of Health (MOH) reported two more MERS-CoV cases, one of them fatal and both from Riyadh.
One of the patients is a 33-year-old man whose contact with camels isn't known. He is not a health worker, and his exposure is listed as primary, meaning he probably didn't contract MERS-CoV (Middle East respiratory syndrome coronavirus) from another patient.
Some parts of the south and central US are among the few hot spots, and flu strains vary by region.
Takeda's dengue vaccine candidate (TAK-003) is safe and effective against dengue virus, according to part 1 of phase 3 clinical trial results published yesterday in the New England Journal of Medicine.
